soul trial oral semaglutide cardiovascular outcomes results 2024 nejm (NEJM 2025): led to a 14% β in major CV events vs placebo in T2DM with ASCVD or CKD β no β in serious AEs. #Semaglutide #CardioDiabetes #updatesinmedicine π¨ Oral Semaglutide 25 mg
Pay in 4 interest-free payments of $6.27 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Jul 31 - Aug 5























